Medical Weight Loss Program at LI Obesity Surgery

At LI Obesity Surgery, we offer a variety of FDA-approved medical weight loss options to help you achieve sustainable results. Whether you’re seeking an alternative to surgery or a complementary treatment to your weight loss plan, our expert team will guide you in choosing the best medication for your specific needs. Explore the different weight loss medications we offer and find the solution that’s right for you.

We offer a comprehensive, multi-disciplinary approach to weight loss, tailored to each patient’s needs, which includes:

  • Monthly visits with your provider to ensure sustainable and long term weight loss
  • Monthly consultations with our on-site nutritionist
  • Personalized meal plans tailored to your needs
  • Monthly weigh- ins to track your progress
  • We provide a private Facebook group to our patients, where you’ll find a wealth of resources including:
    – Low-calorie, high-protein recipes
    – Expert weight loss advice
    – Support from physicians and fellow patients

We offer support groups on the 2nd and 4th Tuesday of every month, designed to enhance your journey towards health and wellness. Our sessions include support for both surgical and non-surgical weight loss, along with access to our Registered Dietitian and psychologists who will provide tailored guidance and ongoing support. Additionally, we offer resources to help you connect with qualified personal trainers in your area, providing you with personalized fitness programs to complement your weight loss goals.

Tirzepatide (Zepbound, Mounjaro)

Tirzepatide, sold under the brand name Mounjaro, is a dual-action injectable medication that targets both GLP-1 and GIP receptors to control blood sugar and reduce appetite. Although currently approved for type 2 diabetes, it has shown exceptional weight loss results in clinical trials and is gaining recognition for its off-label use in weight management.

  • Dual-action GLP-1 and GIP receptor agonist
  • Helps control blood sugar and reduces appetite
  • Significant weight loss results in clinical trials

Semaglutide (Wegovy, Ozempic, Rybelsus)

Semaglutide is a GLP-1 receptor agonist that works by regulating appetite and improving blood sugar levels. Available in both injectable and oral forms, Semaglutide helps patients manage obesity and weight-related conditions. Wegovy is primarily used for weight loss, while Ozempic and Rybelsus are prescribed for patients with type 2 diabetes but also promote weight loss.

  • FDA-approved for weight loss and type 2 diabetes management
  • Available in both injectable and tablet forms
  • Promotes appetite control and weight reduction

Liraglutide (Saxenda)

Liraglutide, also known as Saxenda, is an injectable medication designed for long-term weight management. It works by suppressing appetite, helping patients reduce calorie intake and stick to a lower-calorie diet. Liraglutide is ideal for those with obesity or overweight individuals with weight-related health issues like high blood pressure or type 2 diabetes.

  • FDA-approved for obesity and weight-related conditions
  • Helps control hunger and manage food intake
  • Supports long-term weight management

Qsymia

Qsymia is a combination medication that includes phentermine, an appetite suppressant, and topiramate, which helps patients feel full and satisfied after eating. Qsymia is a long-term weight loss option designed to help patients with obesity or weight-related conditions manage their weight through reduced food intake.

  • Combination of phentermine and topiramate for appetite suppression
  • FDA-approved for long-term weight management
  • Reduces food intake and increases satiety